Hudson Garrett, PhD, is PENTAX Medical’s new global chief clinical officer.
The American Gastroenterological Association Research Foundation and Takeda Pharmaceuticals U.S.A. are offering three new research grants to fund work on inflammatory bowel disease projects.
GI Dynamics announced the final results of its ENDO Trial, the clinical trial for its EndoBarrier therapy in the United States.
The U.S. Preventive Services Task Force included Exact Sciences’ Cologuard in its final 2016 colorectal cancer screening recommendations and clarified Cologuard’s position as equal to other recommended screening tests.
Healthmark Industries launched the NOW! test for checking endoscope safety.
The FDA approved Gilead Sciences’ Epclusa to treat adults with chronic hepatitis C, both with and without cirrhosis.
More articles on GI/endoscopy:
4 key trends in the $2.35B GI/endoscopic devices market
Merit Health Natchez adds Dr. W. Kirk Mullins: 4 points
5 most read GI/endoscopy stories: June 20 — June 24
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
